
The Societal Impact of Stroke: Prevalence, Pathophysiology, and Economic Burden
Panelists examine the societal impact of stroke by outlining its prevalence, underlying pathophysiology, key modifiable risk factors, and the substantial clinical, economic, and long-term disability burden it places on patients and the healthcare system.
Episodes in this series

In this episode, ‘The Societal Impact of Stroke: Prevalence, Pathophysiology, and Economic Burden,’ the experts explored the following questions:
What are the prevalences of the different types of stroke and how do they cause a patient/caregiver burden?
Can you cover the pathophysiology and risk factors with each of the different stroke types?
What is the economic burden associated with stroke on both a population and patient level?
The experts examined the staggering statistics of stroke, noting that large artery and cardioembolic strokes each account for approximately 25% to 35% of all acute ischemic events. David Rose introduced the "Fab Five" modifiable risk factors—hypertension, diabetes, hyperlipidemia, sedentary lifestyle, and smoking—emphasizing that hypertension remains the most prevalent driver of disease. The panel discussed the significant economic impact, with direct and indirect costs exceeding $70 billion annually in the United States. Finally, the conversation addressed the long-term disability caused by stroke, highlighting that it remains the leading cause of admission to inpatient rehabilitation facilities.
Throughout the conversation, the experts provide a comprehensive reflection on the field and the factors that may shape how clinicians approach care moving forward.
In the next episode, ‘Navigating the Stroke Care Continuum: Provider Roles and Patient Education’, panelists will continue their discussion on stroke and highlight the roles of the multidisciplinary care team, primary prevention strategies such as the Mediterranean diet, and the "multiplier effect" of disability associated with recurrent stroke.





